Literature DB >> 29688489

Protective role of the lipid phosphatase Fig4 in the adult nervous system.

Yevgeniya A Mironova1,2, Jing-Ping Lin1, Ashley L Kalinski1, Lucas D Huffman1,3, Guy M Lenk4, Leif A Havton5, Miriam H Meisler3,4,6, Roman J Giger1,2,3,6.   

Abstract

The signaling lipid phosphatidylinositol 3,5-bisphosphate, PI(3,5)P2, functions in vesicular trafficking through the endo-lysosomal compartment. Cellular levels of PI(3,5)P2 are regulated by an enzyme complex comprised of the kinase PIKFYVE, the phosphatase FIG4, and the scaffold protein VAC14. Mutations of human FIG4 cause inherited disorders including Charcot-Marie-Tooth disease type 4J, polymicrogyria with epilepsy, and Yunis-Varón syndrome. Constitutive Fig4-/- mice exhibit intention tremor, spongiform degeneration of neural tissue, hypomyelination, and juvenile lethality. To determine whether PI(3,5)P2 is required in the adult, we generated Fig4flox/-; CAG-creER mice and carried out tamoxifen-induced gene ablation. Global ablation in adulthood leads to wasting, tremor, and motor impairment. Death follows within 2 months of tamoxifen treatment, demonstrating a life-long requirement for Fig4. Histological examinations of the sciatic nerve revealed profound Wallerian degeneration of myelinated fibers, but not C-fiber axons in Remak bundles. In optic nerve sections, myelinated fibers appear morphologically intact and carry compound action potentials at normal velocity and amplitude. However, when iKO mice are challenged with a chemical white matter lesion, repair of damaged CNS myelin is significantly delayed, demonstrating a novel role for Fig4 in remyelination. Thus, in the adult PNS Fig4 is required to protect myelinated axons from Wallerian degeneration. In the adult CNS, Fig4 is dispensable for fiber stability and nerve conduction, but is required for the timely repair of damaged white matter. The greater vulnerability of the PNS to Fig4 deficiency in the mouse is consistent with clinical observations in patients with Charcot-Marie-Tooth disease.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29688489      PMCID: PMC6030899          DOI: 10.1093/hmg/ddy145

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  40 in total

Review 1.  Phosphatidylinositol 3,5-bisphosphate: regulation of cellular events in space and time.

Authors:  Natsuko Jin; Michael J Lang; Lois S Weisman
Journal:  Biochem Soc Trans       Date:  2016-02       Impact factor: 5.407

2.  Deleterious variants of FIG4, a phosphoinositide phosphatase, in patients with ALS.

Authors:  Clement Y Chow; John E Landers; Sarah K Bergren; Peter C Sapp; Adrienne E Grant; Julie M Jones; Lesley Everett; Guy M Lenk; Diane M McKenna-Yasek; Lois S Weisman; Denise Figlewicz; Robert H Brown; Miriam H Meisler
Journal:  Am J Hum Genet       Date:  2009-01       Impact factor: 11.025

3.  Role of the phosphoinositide phosphatase FIG4 gene in familial epilepsy with polymicrogyria.

Authors:  Stéphanie Baulac; Guy M Lenk; Béatrice Dufresnois; Bouchra Ouled Amar Bencheikh; Philippe Couarch; Julie Renard; Peter A Larson; Cole J Ferguson; Eric Noé; Karine Poirier; Christine Hubans; Stéphanie Ferreira; Renzo Guerrini; Reda Ouazzani; Khalid Hamid El Hachimi; Miriam H Meisler; Eric Leguern
Journal:  Neurology       Date:  2014-03-05       Impact factor: 9.910

4.  Rescue of neurodegeneration in the Fig4 null mouse by a catalytically inactive FIG4 transgene.

Authors:  Guy M Lenk; Christen M Frei; Ashley C Miller; Rachel C Wallen; Yevgeniya A Mironova; Roman J Giger; Miriam H Meisler
Journal:  Hum Mol Genet       Date:  2015-11-24       Impact factor: 6.150

5.  Pathogenic mechanism of the FIG4 mutation responsible for Charcot-Marie-Tooth disease CMT4J.

Authors:  Guy M Lenk; Cole J Ferguson; Clement Y Chow; Natsuko Jin; Julie M Jones; Adrienne E Grant; Sergey N Zolov; Jesse J Winters; Roman J Giger; James J Dowling; Lois S Weisman; Miriam H Meisler
Journal:  PLoS Genet       Date:  2011-06-02       Impact factor: 5.917

6.  Murine Fig4 is dispensable for muscle development but required for muscle function.

Authors:  Aaron Reifler; Guy M Lenk; Xingli Li; Linda Groom; Susan V Brooks; Desmond Wilson; Michyla Bowerson; Robert T Dirksen; Miriam H Meisler; James J Dowling
Journal:  Skelet Muscle       Date:  2013-09-01       Impact factor: 4.912

7.  Charcot Marie Tooth disease type 4J with complex central nervous system features.

Authors:  James P Orengo; Pravin Khemani; John W Day; Jun Li; Carly E Siskind
Journal:  Ann Clin Transl Neurol       Date:  2018-01-22       Impact factor: 4.511

8.  Pre-Existing Mature Oligodendrocytes Do Not Contribute to Remyelination following Toxin-Induced Spinal Cord Demyelination.

Authors:  Abbe H Crawford; Richa B Tripathi; Sarah Foerster; Ian McKenzie; Eleni Kougioumtzidou; Matthew Grist; William D Richardson; Robin J M Franklin
Journal:  Am J Pathol       Date:  2016-01-07       Impact factor: 4.307

9.  Myelin membrane wrapping of CNS axons by PI(3,4,5)P3-dependent polarized growth at the inner tongue.

Authors:  Nicolas Snaidero; Wiebke Möbius; Tim Czopka; Liesbeth H P Hekking; Cliff Mathisen; Dick Verkleij; Sandra Goebbels; Julia Edgar; Doron Merkler; David A Lyons; Klaus-Armin Nave; Mikael Simons
Journal:  Cell       Date:  2014-01-16       Impact factor: 41.582

10.  PI(3,5)P2 biosynthesis regulates oligodendrocyte differentiation by intrinsic and extrinsic mechanisms.

Authors:  Yevgeniya A Mironova; Guy M Lenk; Jing-Ping Lin; Seung Joon Lee; Jeffery L Twiss; Ilaria Vaccari; Alessandra Bolino; Leif A Havton; Sang H Min; Charles S Abrams; Peter Shrager; Miriam H Meisler; Roman J Giger
Journal:  Elife       Date:  2016-03-23       Impact factor: 8.140

View more
  8 in total

1.  Cerebral hypomyelination associated with biallelic variants of FIG4.

Authors:  Guy M Lenk; Ian R Berry; Chloe A Stutterd; Moira Blyth; Lydia Green; Gayatri Vadlamani; Daniel Warren; Ian Craven; Miriam Fanjul-Fernandez; Victoria Rodriguez-Casero; Paul J Lockhart; Adeline Vanderver; Cas Simons; Susan Gibb; Simon Sadedin; Susan M White; John Christodoulou; Olga Skibina; Jonathan Ruddle; Tiong Y Tan; Richard J Leventer; John H Livingston; Miriam H Meisler
Journal:  Hum Mutat       Date:  2019-02-28       Impact factor: 4.878

2.  Severe Consequences of SAC3/FIG4 Phosphatase Deficiency to Phosphoinositides in Patients with Charcot-Marie-Tooth Disease Type-4J.

Authors:  Assia Shisheva; Diego Sbrissa; Bo Hu; Jun Li
Journal:  Mol Neurobiol       Date:  2019-07-16       Impact factor: 5.590

Review 3.  Phosphoinositides in autophagy: current roles and future insights.

Authors:  Lavinia Palamiuc; Archna Ravi; Brooke M Emerling
Journal:  FEBS J       Date:  2019-11-21       Impact factor: 5.622

Review 4.  Animal Models of Tremor: Relevance to Human Tremor Disorders.

Authors:  Ming-Kai Pan; Chun-Lun Ni; Yeuh-Chi Wu; Yong-Shi Li; Sheng-Han Kuo
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2018-10-09

5.  Mutations in PIK3C2A cause syndromic short stature, skeletal abnormalities, and cataracts associated with ciliary dysfunction.

Authors:  Dov Tiosano; Hagit N Baris; Anlu Chen; Marrit M Hitzert; Markus Schueler; Federico Gulluni; Antje Wiesener; Antonio Bergua; Adi Mory; Brett Copeland; Joseph G Gleeson; Patrick Rump; Hester van Meer; Deborah A Sival; Volker Haucke; Josh Kriwinsky; Karl X Knaup; André Reis; Nadine N Hauer; Emilio Hirsch; Ronald Roepman; Rolph Pfundt; Christian T Thiel; Michael S Wiesener; Mariam G Aslanyan; David A Buchner
Journal:  PLoS Genet       Date:  2019-04-29       Impact factor: 5.917

6.  Whole exome sequencing establishes diagnosis of Charcot-Marie-Tooth 4J, 1C, and X1 subtypes.

Authors:  Kleita Michaelidou; Ioannis Tsiverdis; Sophia Erimaki; Dimitra Papadimitriou; Georgios Amoiridis; Alexandros Papadimitriou; Panayiotis Mitsias; Ioannis Zaganas
Journal:  Mol Genet Genomic Med       Date:  2020-02-05       Impact factor: 2.183

7.  Human organ donor-derived vagus nerve biopsies allow for well-preserved ultrastructure and high-resolution mapping of myelinated and unmyelinated fibers.

Authors:  Leif A Havton; Natalia P Biscola; Esther Stern; Plamen V Mihaylov; Chandrashekhar A Kubal; John M Wo; Anita Gupta; Elizabeth Baronowsky; Matthew P Ward; Deborah M Jaffey; Terry L Powley
Journal:  Sci Rep       Date:  2021-12-13       Impact factor: 4.379

8.  Adeno-associated virus gene therapy to the rescue for Charcot-Marie-Tooth disease type 4J.

Authors:  John Svaren
Journal:  J Clin Invest       Date:  2021-06-01       Impact factor: 19.456

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.